Beyond the "Magnificent Seven": These 3 Breakout AI Stocks Are Disrupting the Industry

The article highlights Taiwan Semiconductor, Broadcom, and Micron as three AI stocks it believes deserve to be grouped with the Magnificent Seven, citing strong demand trends and expanding AI chip revenues. Micron management projects the HBM market to grow from $35 billion in 2025 to $100 billion by 2028, while Taiwan Semiconductor expects nearly 60% CAGR in AI chip revenue from 2024 to 2029. Broadcom said AI semiconductor revenue rose 104% to $8.4 billion in Q1 and custom AI chips could exceed $100 billion in annual revenue by 2027.

Analysis

The market is still treating AI capex as a one-way trade, but the better lens is bottlenecks: the highest-quality monetization sits in the picks-and-shovels layer where incremental demand converts to pricing power faster than end-demand can be absorbed. That favors AVGO most cleanly because custom silicon monetizes hyperscaler budgets without requiring the same broad-based unit growth as GPUs, and it likely captures share as large buyers optimize for TCO rather than novelty. TSM is the critical capacity gatekeeper: as advanced-node utilization tightens, its leverage comes less from headline AI excitement and more from the ability to force better mix, longer lead times, and pricing discipline across the ecosystem.

MU is the most asymmetric from here because memory is the one part of the stack where supply discipline can produce a multi-quarter earnings tailwind even if AI enthusiasm cools. The key second-order effect is that HBM scarcity does not just raise supplier margins; it can slow GPU deployment at the margin, which may shift some hyperscaler spend toward custom ASICs and away from merchant accelerators. That is quietly supportive of AVGO and, indirectly, of TSM’s advanced packaging and leading-edge wafer utilization.

The contrarian risk is that consensus is extrapolating a 2025-2027 capex cycle into a straight line while ignoring how fast supply responses can compress returns once fabs and HBM capacity come online. AVGO’s biggest near-term vulnerability is design-in concentration: if one or two hyperscalers pause or re-spec custom programs, revenue air pockets can appear with little warning. TSM’s risk is geopolitical, but over the next 6-12 months the more relevant issue is not disruption, it is whether AI demand broadens enough to offset any cyclicality in handset/industrial end markets. NVDA remains less compelling tactically because the article reinforces a relative shift toward alternatives to GPU-only architectures rather than an acceleration of its share gains.

Key Decisions for Investors

• Overweight AVGO versus NVDA on a 6-12 month horizon: long AVGO / short NVDA as a relative-value pair, targeting continued hyperscaler ASIC adoption and better earnings durability from custom silicon; stop if merchant GPU shipment trends re-accelerate.
• Add MU on weakness for a 3-6 month trade: memory tightness is still in early innings, and HBM pricing/availability should keep estimates moving higher; size for volatility because the stock can de-rate quickly if capacity expansions get announced ahead of demand.
• Use TSM as a core AI infrastructure hold for 12+ months, but buy only on pullbacks: the trade is not about multiple expansion, it is about persistent pricing power and mix shift; risk/reward improves if advanced-node utilization data remains tight.
• Consider a covered-call overlay on AVGO into the next earnings cycle: implied volatility should remain elevated, and the business has strong fundamental support, but the stock is vulnerable to any guidance miss from customer concentration.
• Avoid chasing NVDA at current levels; if you want exposure to AI infrastructure, express it through AVGO/TSM/MU where second-order bottlenecks and supply leverage look more attractive.